Comparison of Serum Free and Bioavailable 25-Hydroxyvitamin D Levels in Alzheimer's Disease and Healthy Control Patients

Ertilav E., BARCIN N. E., ÖZDEM S.

LABORATORY MEDICINE, vol.52, no.3, pp.219-225, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 52 Issue: 3
  • Publication Date: 2021
  • Doi Number: 10.1093/labmed/lmaa066
  • Journal Name: LABORATORY MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, CINAHL, EMBASE, MEDLINE
  • Page Numbers: pp.219-225
  • Keywords: Alzheimer's disease, free 25-hydroxyvitamin D, bioavailable 25-hydroxyvitamin D, cognitive impairment, dementia, vitamin D binding protein, VITAMIN-D DEFICIENCY, D-BINDING PROTEIN, RISK, 1-ALPHA-HYDROXYLASE, DEMENTIA
  • Akdeniz University Affiliated: Yes

Abstract

Objective: Many studies have investigated lower 25-hydroxyvitamin D (25[OH]D) levels in patients with Alzheimer's disease (AD) compared with those in control patients. In the present study, we aimed to evaluate serum free and bioavailable 25(OH)D levels in patients with AD and in healthy control patients.